Skip to content

Clinical trials

Phase 1 Substance-Related Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Substance-Related Disorders Phase: Phase 1 Clear all

170 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20032
20049
20053
20065
200710
200815
200914
201013
201113
201210
20137
20143
20152
20164
20176
20182
20193
20203
20218
20222
20235
20245
20257
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed131
Recruiting9
Withdrawn9
Terminated6
Unknown status6
Not yet recruiting5
Active, not recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute on Drug Abuse (NIDA)19
Baylor College of Medicine14
GlaxoSmithKline11
University of California, Los Angeles10
University Hospital, Basel, Switzerland8
Yale University5
Brown University4
Oregon Research Institute4
University of Washington4
Boston Children's Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Substance-Related Disorders170
Alcoholism14
Cocaine-Related Disorders13
Opioid-Related Disorders13
Marijuana Abuse10
Mental Disorders8
Pain7
Tobacco Use Disorder7
Anxiety Disorders6
Mood Disorders6

Trials

Showing 26 to 50 of 170. Each trial links to its page on Pharma Observatory.

70 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.